An SEC filing shows Amazon (AMZN.O) held 164 mln shares of Anthropic non-voting preferred stock as of Sept. 30.

INIBO, a Korean botulinum-toxin product in which Huaxi Bio has a strategic stake, received approval from the National Medical Products Administration; Huaxi is the exclusive mainland China partner. The arrangement combines strategic investment and market cooperation to broaden Huaxi’s medical-aesthetics product coverage, diversify its business mix and support long-term development. This extends a prior exclusive-agency collaboration with Korea’s INIBIO for a facial-rejuvenation injection.

西班牙交通部長：首相沒有要求我辭職，這也不符合我的性格。